Mesoscale DNA features impact APOBEC3A and APOBEC3B deaminase activity and shape tumor mutational landscapes
- PMID: 38499542
- PMCID: PMC10948877
- DOI: 10.1038/s41467-024-45909-5
Mesoscale DNA features impact APOBEC3A and APOBEC3B deaminase activity and shape tumor mutational landscapes
Abstract
Antiviral DNA cytosine deaminases APOBEC3A and APOBEC3B are major sources of mutations in cancer by catalyzing cytosine-to-uracil deamination. APOBEC3A preferentially targets single-stranded DNAs, with a noted affinity for DNA regions that adopt stem-loop secondary structures. However, the detailed substrate preferences of APOBEC3A and APOBEC3B have not been fully established, and the specific influence of the DNA sequence on APOBEC3A and APOBEC3B deaminase activity remains to be investigated. Here, we find that APOBEC3B also selectively targets DNA stem-loop structures, and they are distinct from those subjected to deamination by APOBEC3A. We develop Oligo-seq, an in vitro sequencing-based method to identify specific sequence contexts promoting APOBEC3A and APOBEC3B activity. Through this approach, we demonstrate that APOBEC3A and APOBEC3B deaminase activity is strongly regulated by specific sequences surrounding the targeted cytosine. Moreover, we identify the structural features of APOBEC3B and APOBEC3A responsible for their substrate preferences. Importantly, we determine that APOBEC3B-induced mutations in hairpin-forming sequences within tumor genomes differ from the DNA stem-loop sequences mutated by APOBEC3A. Together, our study provides evidence that APOBEC3A and APOBEC3B can generate distinct mutation landscapes in cancer genomes, driven by their unique substrate selectivity.
© 2024. The Author(s).
Conflict of interest statement
R.B. has served as a compensated consultant for Pfizer and Health Advances. The remaining authors declare no competing interests.
Figures






Update of
-
Mesoscale DNA Features Impact APOBEC3A and APOBEC3B Deaminase Activity and Shape Tumor Mutational Landscapes.bioRxiv [Preprint]. 2023 Aug 2:2023.08.02.551499. doi: 10.1101/2023.08.02.551499. bioRxiv. 2023. Update in: Nat Commun. 2024 Mar 18;15(1):2370. doi: 10.1038/s41467-024-45909-5. PMID: 37577509 Free PMC article. Updated. Preprint.
Similar articles
-
Mesoscale DNA Features Impact APOBEC3A and APOBEC3B Deaminase Activity and Shape Tumor Mutational Landscapes.bioRxiv [Preprint]. 2023 Aug 2:2023.08.02.551499. doi: 10.1101/2023.08.02.551499. bioRxiv. 2023. Update in: Nat Commun. 2024 Mar 18;15(1):2370. doi: 10.1038/s41467-024-45909-5. PMID: 37577509 Free PMC article. Updated. Preprint.
-
Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancer.PLoS Genet. 2023 Nov 30;19(11):e1011043. doi: 10.1371/journal.pgen.1011043. eCollection 2023 Nov. PLoS Genet. 2023. PMID: 38033156 Free PMC article.
-
Enzyme cycling contributes to efficient induction of genome mutagenesis by the cytidine deaminase APOBEC3B.Nucleic Acids Res. 2017 Nov 16;45(20):11925-11940. doi: 10.1093/nar/gkx832. Nucleic Acids Res. 2017. PMID: 28981865 Free PMC article.
-
Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression.Viruses. 2017 Aug 21;9(8):233. doi: 10.3390/v9080233. Viruses. 2017. PMID: 28825669 Free PMC article. Review.
-
APOBEC3B: pathological consequences of an innate immune DNA mutator.Biomed J. 2015 Mar-Apr;38(2):102-10. doi: 10.4103/2319-4170.148904. Biomed J. 2015. PMID: 25566802 Review.
Cited by
-
The cytidine deaminase APOBEC3C has unique sequence and genome feature preferences.Genetics. 2024 Aug 7;227(4):iyae092. doi: 10.1093/genetics/iyae092. Genetics. 2024. PMID: 38946641 Free PMC article.
-
Regulation, functional impact, and therapeutic targeting of APOBEC3A in cancer.DNA Repair (Amst). 2024 Sep;141:103734. doi: 10.1016/j.dnarep.2024.103734. Epub 2024 Jul 20. DNA Repair (Amst). 2024. PMID: 39047499 Review.
-
Defining APOBEC-induced mutation signatures and modifying activities in yeast.Methods Enzymol. 2025;713:115-161. doi: 10.1016/bs.mie.2024.11.041. Epub 2025 Apr 2. Methods Enzymol. 2025. PMID: 40250951 Free PMC article.
-
An in vitro cytidine deaminase assay to monitor APOBEC activity on DNA.Methods Enzymol. 2025;713:201-219. doi: 10.1016/bs.mie.2024.11.037. Epub 2024 Dec 7. Methods Enzymol. 2025. PMID: 40250954 Free PMC article.
-
Next generation APOBEC3 inhibitors: optimally designed for potency and nuclease stability.Nucleic Acids Res. 2025 Mar 20;53(6):gkaf234. doi: 10.1093/nar/gkaf234. Nucleic Acids Res. 2025. PMID: 40156866 Free PMC article.
References
-
- Swanton C, McGranahan N, Starrett GJ, Harris RS. APOBEC enzymes: mutagenic fuel for cancer evolution and heterogeneity. Cancer Discov. 2015;5:704–12. doi: 10.1158/2159-8290.CD-15-0344. - DOI - PMC - PubMed
-
- Harris, R. S. & Liddament, M. T. Retroviral restriction by APOBEC proteins. Nat. Rev. Immunol.4, 868–877. 10.1038/nri1489 (2004). - PubMed